Novel transcript, antisense to leucine-rich repeat-containing G-protein coupled receptor 6 (ENSG00000295211)

This target is a novel transcript located antisense to the LGR6 gene. It is identified as a long non-coding RNA likely involved in post-transcriptional regulation of the LGR6 locus, based on functional analogies to other natural antisense transcripts[2][4][5]. While natural antisense transcripts can affect gene expression through a variety of mechanisms—including modification of chromatin, transcriptional interference, and RNA masking—the specific role, expression pattern, and biological consequences of this antisense transcript to LGR6 remain unknown. Notably, there is no current evidence that it functions as a drug, biomarker, or therapeutic target. If you require structured data for programmatic use, each field above is directly mapped to common target characterization attributes. For this entity, there are *no known functions, disease links, drugs, or mechanisms of action specific to ENSG00000295211*; all biological and molecular associations are inferred from general NAT/lncRNA knowledge, not from direct experimental evidence for this transcript.

Other names

Natural antisense transcript to LGR6antisense ncRNA to LGR6ENSG00000295211

Not applicable; no drugs target this entity. General NAT mechanisms may include RNA masking, transcriptional interference, dsRNA-dependent silencing, or epigenetic modification